PF-Atlas › Clinical Trials › NCT04344041
COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients
cholecalciferol 200,000 IU · Phase 3
Registry ID
NCT04344041
Phase
Phase 3
Status
Completed
Drug / intervention
cholecalciferol 200,000 IU
Sponsor
University Hospital, Angers
Start
2020-04-15
About this trial
cholecalciferol 200,000 IU is evaluated in NCT04344041, a Phase 3 idiopathic pulmonary fibrosis study sponsored by University Hospital, Angers. Current status: Completed.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT04344041 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.